Скачать или смотреть 🇺🇸 America Biosecure Act Explained in Tamil | 💊 Indian Pharma | Divis Lab, Piramal Pharma | STOCKER

Open Your Demat Account With Dhan App👇:

https://join.dhan.co/?invite=IUBDB78332


📢 DISCLAIMER:

This video is intended solely for educational and learning purposes.
We have no intention of involving clients in any trading or investing activities.
It is important to clarify that we are not registered with
SEBI (Securities and Exchange Board of India).

We strongly advise you to consult with a qualified financial advisor before
making any financial decisions. Seeking guidance from a financial
professional can help you make well-informed choices that align
with your specific financial circumstances and goals.

THIS VIDEO IS FOR EDUCATIONAL PURPOSES ONLY AND
WE DO NOT INTEND TO INDUCE CLIENTS INTO ANY TRADING OR INVESTING ACTIVITY.

Investment in securities (mutual funds & stock market) is subject to market risk.
Read all related documents carefully before investing.


---

Copyright Disclaimer Under Section 107 of the Copyright Act 1976:
Allowance is made for "fair use" for purposes such as criticism, comment, news reporting, teaching, scholarship, and research.
Fair use is a use permitted by copyright statute that might otherwise be infringing.
Non-profit, educational, or personal use tips the balance in favor of fair use.

---

🧾 Description:

The U.S. Biosecure Act aims to protect American science and medicine from data and DNA leaks by restricting partnerships with certain Chinese CDMO and CRDMO companies.
This move could benefit Indian pharma companies like Divis Lab, Laurus Lab, Piramal Pharma, Anthem Bioscience, Syngene, and Neuland Laboratories, as they already operate in CDMO/CRDMO segments and can attract new U.S. contracts.

The Act has passed both the House (306–81) and Senate (77–20) and now awaits the President’s signature to become law.

Stay tuned for how this shift may reshape the global pharma supply chain and give Indian firms a major edge! 🇮🇳📈


---

🔖 Keywords

Biosecure Act, US Biosecure Act, Biosecure Act Explained, US China Pharma Ban, CDMO Companies, CRDMO Companies, Indian Pharma Stocks, Divis Lab, Laurus Lab, Piramal Pharma, Anthem Bioscience, Syngene, Neuland Laboratories, Pharma Sector News, Pharma Stocks to Watch, Biosecure Act India Impact, US Restrict Chinese Pharma, Indian Pharma Opportunity, Pharma Market Shift, Stock Market News, Global Pharma Trends, Biosecure Act in Tamil, US Biosecure Act in Tamil, Biosecure Act Explained in Tamil, US China Pharma Ban in Tamil, CDMO Companies in Tamil, CRDMO Companies in Tamil, Indian Pharma Stocks in Tamil, Divis Lab in Tamil, Laurus Lab in Tamil, Piramal Pharma in Tamil, Anthem Bioscience in Tamil, Syngene in Tamil, Neuland Laboratories in Tamil, Pharma Sector News in Tamil, Biosecure Act India Impact in Tamil, Indian Pharma Opportunity in Tamil, Pharma Stocks to Watch in Tamil, US Restrict Chinese Pharma in Tamil, Stock Market News in Tamil, Global Pharma Trends in Tamil

---

🔖 Hashtags :

#BiosecureAct #Trump #Tamil #USChinaTension #PharmaNews #IndianPharma #CDMO #CRDMO #DivisLab #LaurusLab #PiramalPharma #Syngene #AnthemBioscience #NeulandLaboratories #PharmaStocks #GlobalPharma #USPolicy #StockMarketNews #MakeInIndia #HealthcareInnovation #BiotechNews #PharmaGrowth